BevCanna Enterprises Inc (CSE:BEV) (OTCMKTS:BVNNF) has revealed it is set to bring a new CBD-infused immune-supporting drink to the US and Canadian markets.
The beverage will be launched under the firm's health and wellness brand Lev and is expected to be in 60ml and 250ml sizes.
It will be based on the popular Trace beverage, a non-CBD version, which is already approved by Health Canada.
BevCanna has the rights to develop this formulation due to its exclusive license agreement with Naturo Group.
"Health and wellness are very much top of mind for consumers today and developing a beverage that is not only appealing to drink, but that also boosts immunity and wellness is a natural fit for BevCanna," John Campbell, the chief strategy officer at BevCanna said in a statement.
The new drink will be plant-based, with fulvic and humic minerals, which occur naturally in nutrient-rich soils and mineral-dense rock sediments.
The firm said the key benefits include cognitive performance, gut health, and immune function. It also aids the body to metabolize carbs, fats, and proteins, it added.
The drink is currently in the testing stage, with plans to launch in the US this year, and in Canada upon regulatory approval of the mineral fortification of cannabis beverages.
The Trace drink is currently sold in more than 3,000 retailers across Canada, including 7/11, Loblaws, London Drugs, Metro and Farm Boy, and is expanding into the US market.
Bevcanna also said it had entered a marketing and investor relations agreement with Aktiencheck.de corporate branding, marketing, online corporate communications and investor relations services to the company for one month for total cash consideration of €50,000, which was paid upon entry into the agreement.
Shares in Toronto advanced around 29% to C$0.40 in early deals.
Contact the author at [email protected]